Nektar Therapeutics (Nasdaq: NKTR) today announced the presentation of a poster highlighting new preclinical data on NKTR-0165 at the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress.
Nektar Therapeutics ( NASDAQ:NKTR ) shareholders might be concerned after seeing the share price drop 11% in the last...
Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences: